AI Science Tracker
EN

Fuzong Clinical Medical College of Fujian Medical University

1 discovery from 2025

Discoveries

Development and Validation of the Early Gastric Carcinoma Prediction Model in Post-Eradication Patients with Intestinal Metaplasia

Source check: Source checked. Not independent scientific confirmation.

Finding: Boruta/SHAP feature selection and comparison of 21 ML methods generated a five-feature CatBoost early-gastric-cancer model from 214 patients; internal AUC .743, independent Fujian external AUC .905. Small retrospective cohorts; external signal warrants cautious interpretation. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: CatBoost

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Boruta/SHAP feature selection and comparison of 21 ML methods generated a five-feature CatBoost early-gastric-cancer model from 214 patients; internal AUC .743, independent Fujian external AUC .905. Small retrospective cohorts; external signal warrants cautious interpretation.
Test and result
Boruta/SHAP feature selection and comparison of 21 ML methods generated a five-feature CatBoost early-gastric-cancer model from 214 patients; internal AUC .743, independent Fujian external AUC .905. Small retrospective cohorts; external signal warrants cautious interpretation.
Limitation / still unknown
No prospective clinical benefit or broader external validity is established by the documented study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.mdpi.com/2072-6694/17/13/2158

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.